Keyphrases
After Surgery
16%
Breast Cancer
16%
Breast Cancer Patients
16%
Chi-square
16%
Circulating Tumor DNA (ctDNA)
100%
Clinical Outcome Prediction
16%
Clinical Outcomes
100%
Clinical Relapse
83%
Disease Course
16%
Disease Monitoring
16%
Disease-free Interval
16%
Early Detection
16%
High Sensitivity
16%
Molecular Relapse
66%
Mutant Allele Frequency
33%
Outcome Prediction
16%
Pathological Complete Response
66%
Pathological Response
16%
Patient Outcomes
16%
Peripheral Blood
33%
Preemptive Intervention
16%
Prognosis Prediction
16%
Remission
16%
Sequencing Cost
16%
Somatic Variants
16%
Symptom Onset
16%
Therapeutic Response
16%
Timing of Surgery
16%
Triple-negative Breast Cancer
100%
Tumor
16%
Tumor-normal
16%
Turnaround Time
16%
Whole Exome Sequencing
16%
Working Diagnosis
16%
Medicine and Dentistry
Allele
33%
Breast Cancer
16%
Circulating Tumor DNA
100%
Disease Course
16%
Diseases
50%
Exome Sequencing
16%
Health Care Cost
16%
Neoplasm
33%
Somatics
16%
Treatment Response
16%
Triple Negative Breast Cancer
100%
Biochemistry, Genetics and Molecular Biology
Allele
50%
Circulating Tumor DNA
100%
Exome Sequencing
25%
Turnaround Time
25%
Immunology and Microbiology
Allele
100%
Turnaround Time
50%
Whole Exome Sequencing
50%
Neuroscience
Circulating Tumor DNA
100%
Exome Sequencing
25%
Somatics
25%